Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism

Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism

US Patent 12298308 · Granted May 13, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combined markers for metastatic cancer and uses thereof2024
Combined markers for metastatic cancer and uses thereof2024
High resolution intravital imaging and uses thereof2024
TMEM active test and uses thereof in diagnosis, prognosis and treatment of tumor2024
Method for treating neoadjuvant chemotherapy-induced metastasis2023
Method for treating neoadjuvant chemotherapy-induced metastasis2023
High resolution intravital imaging and uses thereof2023
Phosphocofilin: cofilin co-localization intensity as a predictor of metastatic r2021
Methods involving MenaINV in screening for inhibitors of cancer invasion and met2021
Microfluidic intravital window2018
Method of enhancing the efficacy of anti-hepatocyte growth factor receptor breas2018
Human invasion signature for prognosis of metastatic risk2018